Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Centogene AG

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company’s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. Centogene has developed a global proprietary rare disease platform based on our real-world data repository with over 2.0 billion weighted data points from over 450,000 patients representing 115 different countries as of August 31, 2019, or an average of over 500 data points per patient. The Company’s platform includes epidemiologic, phenotypic and genetic data that reflects a global population, and also a biobank of these patients’ blood samples. Centogene believes this represents the only platform that comprehensively analyzes multi-level data to improve the understanding of rare hereditary diseases, which can aid in the identification of patients and improve our pharmaceutical partners’ ability to bring orphan drugs to the market. As of August 31, 2019, the Company collaborated with over 35 pharmaceutical partners for over 30 different rare diseases. *

 

Period Start 2001-12-01 renamed date ca
  Group Centogene (Group)
  Predecessor Arcensus AG
Products Industry molecular diagnostics
  Industry 2 genome sequencing
Persons Person Rolfs, Arndt (Arcensus 202012– Managing Director before Univ Rostock Prof + Centogene 201406– CEO + Founder)
  Person 2 Stoffelen, Richard (Centogene 201805 CFO)
     
Region Region Rostock
  Country Germany
  Street 7 Am Strande
  City 18055 Rostock
  Tel +49-381-80113-400
    Address record changed: 2020-12-11
     
Basic data Employees D: 101 to 500 (2017-05-31)
     
    * Document for �About Section�: Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock.
     
   
Record changed: 2020-12-11

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Centogene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top